FDA Inspection 1315764 — Dr. Yongzhong Luo
The FDA completed an inspection of Dr. Yongzhong Luo on Apr 17, 2026 in Changsha. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 17, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Changsha (China)
Additional Details
Clinical Investigator (CI)